---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-172782"
form_type: "8-K"
ticker: null
cik: "0001651311"
company_name: "Merus N.V."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:03:59.221560+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Merus appoints Fabian Zohren as CMO with $503K salary; CBO Liu and former CMO Joe depart

## Summary
- Fabian Zohren named Chief Medical Officer effective July 1, 2024, succeeding Andrew Joe.
- Zohren's base salary $503,000, target bonus 40%, option for 183,943 shares vesting over 4 years.
- Hui Liu (CBO) and Andrew Joe (outgoing CMO) separated same date; severance per agreements.
- Liu receives accelerated vesting of 3,000 RSUs and $17,500 lump sum; option extended to Dec 31, 2024.
- Joe enters 3-month consulting agreement at $41,000/month; option extended to 3 months post-consulting.

## SEC filing metadata
- accession: 0001193125-24-172782
- form_type: 8-K
- cik: 0001651311
- company_name: Merus N.V.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651311/000119312524172782/0001193125-24-172782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651311/000119312524172782/d862441d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-172782
- JSON: https://secwatch.observer/filing/0001193125-24-172782.json
- Plain text: https://secwatch.observer/filing/0001193125-24-172782.txt

## Key facts
- Executive change
  Fabian Zohren was appointed as Chief Medical Officer at Merus N.V..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: On June 30, 2024, the Board of Directors (the “Board”) of Merus N.V. (the “Company”) appointed Fabian Zohren, M.D., Ph.D. to serve as the Company’s Chief Medical Officer, effective as of July 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651311/000119312524172782/0001193125-24-172782-index.htm
- Executive change
  Andrew Joe departed as Chief Medical Officer at Merus N.V..
  - Action: separated
  - Role: Chief Medical Officer
  source text: succeeding Andrew Joe, M.D. in such role
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651311/000119312524172782/0001193125-24-172782-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.